Blog
RSS FeedPosted by Michael Wonder on 17 Mar 2020
Erlotinib new exchange groups
13 March 2020 - As of April, erlotinib is included as an exchange group on the list of goods for ...
Posted by Michael Wonder on 15 Mar 2020
Mending the broken social contract for pharmaceutical pricing and innovation
13 March 2020 - The biopharmaceutical industry is under unprecedented assault by the public and politicians. ...
Posted by Michael Wonder on 10 Mar 2020
White House principles for reducing drug costs
10 March 2020 - In our partisan times, an opportunity for lawmakers to work across the aisle and get something done. ...
Posted by Michael Wonder on 08 Mar 2020
Price controls imposed by shortsighted politicians keep new life-saving drugs out
5 March 2020 - Politicians need to step outside the Ottawa bubble and understand how their policies impact the lives of ...
Posted by Michael Wonder on 05 Mar 2020
The U.S. has a problem with prescription drug prices. Canada shouldn’t try to fix it.
2 March 2020 - President Donald Trump and the U.S. Congress are scrambling to find ways to make medicines more ...
Posted by Michael Wonder on 04 Mar 2020
Sanofi, fighting back in insulin price debate, says its net prices fell 11%
4 March 2020 - Politicians have called price increases egregious, while large insulin makers have become prime targets for criticism in ...
Posted by Michael Wonder on 04 Mar 2020
Drug shortages in the United States. Are some prices too low?
3 March 2020 - The US public identified lowering prescription drug prices as the top health priority for Congress in 2019. ...
Posted by Michael Wonder on 04 Mar 2020
Changes in list prices, net prices, and discounts for branded drugs in the US, 2007-2018
3 March 2020 - Using 2007-2018 net pricing data on branded pharmaceutical products in the US, list prices increased by 159% ...
Posted by Michael Wonder on 02 Mar 2020
U.K. sets red lines on drug prices, food in U.S. trade talks
2 March 2020 - Johnson’s government publishes goals for negotiations. ...
Posted by Michael Wonder on 26 Feb 2020
Why prescription drug costs are big issue for South Carolina voters
25 February 2020 - The rising cost of prescription drugs is a problem nationwide, but it's particularly acute in South ...
Posted by Michael Wonder on 25 Feb 2020
Senate Republican gets on board with government drug price negotiations
25 February 2020 - Arizona Sen. Martha McSally is introducing a drug pricing bill this week that would allow Medicare to ...
Posted by Michael Wonder on 25 Feb 2020
VA could lead way for nation on lower drug pricing
24 February 2020 - It is no secret that prescription drug prices are a hot-button issue — and understandably so. ...
Posted by Michael Wonder on 25 Feb 2020
What states are doing to combat rising prescription drug prices
24 February 2020 - Prescription drug-price transparency alone is not enough to stem skyrocketing costs, but it is considered an important ...
Posted by Michael Wonder on 23 Feb 2020
3 actions Congress can take to reduce drug prices
21 February 2020 - The high prices Americans pay for drugs has emerged as a major health policy concern. ...
Posted by Michael Wonder on 23 Feb 2020
Stalled initiatives to cut drug prices frustrate Trump
21 February 2020 - President seeks a signature accomplishment on the high-profile issue, as polling shows unfavorable public opinion. ...